Atrial Fibrillation Algorithms Clinical Validation Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 573 participants.

Also called NCT04699812

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 573 participants (enrolled count) (from the registry)
Sponsor
  • Apple Registry lists this organization as the lead sponsor
  • IQVIA Pty Ltd Registry lists this organization as a collaborator
Registry
  • NCT NCT04699812
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04699812. Non-randomized; no masking; primary purpose screening. Start 2020-11-16 (actual); primary completion 2021-04-19 (actual). Results posted on 2022-08-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Fibrillation Algorithms Clinical Validation Study
Intervention (Device)
ELECTROCARDIOGRAM (ECG (electrocardiogram)) PATCH WEAR
Lead sponsor
Apple Inc. (class: industry)
Collaborator
IQVIA Pty Ltd (class: industry)

Record details

Record id
cardio:ct-nct04699812
Content hash
1c91794103ffe69f099cef6cc401275c99a36c769d14dabc51fe5b57f92fdb30